Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
C
Details...
Enter Symbol
(NYSE: EBS)
Sector: Medical
Current Price :
$14.21
52 Week Low
$12.91
52 Week High
$16.90
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
35M
Market Cap:
$0.54B
Avg Volume:
251060
P/E Ratio:
18.690
PEG Ratio:
1.820
1m
3m
6m
1y
2y
Opinion and Analysis
Emergent Biosolutions (EBS) Acquires Commercial Rights To Pandemic Influenza Vaccine Candidate
Dec 28, 2012 01:53 PM |
EBS
Another 636% Jump In Sales For This Biotech?
Jul 18, 2012 02:11 PM |
EBS
A Nice Start To The Week
May 29, 2012 06:33 PM |
AAPL
,
ALL
,
AMZN
,
CRUS
,
EBS
,
EGY
More Articles on EBS..
Press Releases
Emergent BioSolutions to Webcast Presentation at Jefferies 2013 Global Healthcare Conference
May 20, 2013 07:00 AM |
EBS
Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday May 23, 2013 at 9:00 AM Eastern; Webcast Will Be Available
May 16, 2013 07:00 AM |
EBS
Emergent BioSolutions to Webcast Presentation at Bank of America Merrill Lynch 2013 Health Care Conference
May 09, 2013 07:00 AM |
EBS
More Press Releases on EBS..
SEC Filings
Form 4 Emergent BioSolutions For: Mar 14 Filed by: El-Hibri Fuad (10K)
Mar 18, 2013 07:28 PM
Form 4 Emergent BioSolutions For: Mar 14 Filed by: Chatfield Steven (10K)
Mar 18, 2013 02:29 PM
Form 4 Emergent BioSolutions For: Mar 14 Filed by: Havey Adam (10K)
Mar 18, 2013 02:28 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
EBS
Compare to S&P
YTD
-5.61 %
-13.44 %
4 Weeks
5.36 %
5.47 %
12 Weeks
-8.41 %
-11.49 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
144.44 %
EPS Growth in Last Year:
-43.59 %
Sales Growth in Last Quarter:
42.07 %
Sales Growth in Last Quarter:
-12.36 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##